HealthEquity, Inc. (HQY): Price and Financial Metrics


HealthEquity, Inc. (HQY)

Today's Latest Price: $57.66 USD

2.52 (4.57%)

Updated Oct 23 4:00pm

Add HQY to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 9 in Medical - Health Insurance

See all "A" rated Strong Buy stocks

HQY Stock Summary

  • The price/operating cash flow metric for Healthequity Inc is higher than 88.98% of stocks in our set with a positive cash flow.
  • With a year-over-year growth in debt of 2,677.83%, Healthequity Inc's debt growth rate surpasses 98.96% of about US stocks.
  • Revenue growth over the past 12 months for Healthequity Inc comes in at 126.4%, a number that bests 95.55% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to HQY, based on their financial statements, market capitalization, and price volatility, are XPER, CREE, KMPH, URG, and ADMP.
  • Visit HQY's SEC page to see the company's official filings. To visit the company's web site, go to www.healthequity.com.

HQY Stock Price Chart Interactive Chart >

Price chart for HQY

HQY Price/Volume Stats

Current price $57.66 52-week high $88.78
Prev. close $55.14 52-week low $34.40
Day low $55.83 Volume 754,800
Day high $58.09 Avg. volume 911,548
50-day MA $53.98 Dividend yield N/A
200-day MA $58.00 Market Cap 4.43B

HealthEquity, Inc. (HQY) Company Bio


HealthEquity Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company was founded in 2002 and is based in Draper, Utah.

HQY Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$57.66$38.09 -28%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Healthequity Inc. To summarize, we found that Healthequity Inc ranked in the 39th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Healthequity Inc, consider:

  • Its compound free cash flow growth rate, as measured over the past 5.45 years, is 0.51% -- higher than 80.45% of stocks in our DCF forecasting set.
  • Healthequity Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.
  • The weighted average cost of capital for the company is 11. This value is greater than 88.28% stocks in the Technology sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-30%
1%-29%
2%-28%
3%-28%
4%-27%
5%-26%

ADI, CDK, FIVN, UEIC, and ALRM can be thought of as valuation peers to HQY, in the sense that they are in the Technology sector and have a similar price forecast based on DCF valuation.


HQY Latest News Stream


Event/Time News Detail
Loading, please wait...

HQY Latest Social Stream


Loading social stream, please wait...

View Full HQY Social Stream

Latest HQY News From Around the Web

Below are the latest news stories about Healthequity Inc that investors may wish to consider to help them evaluate HQY as an investment opportunity.

HealthEquity: A Unique Long-Term Opportunity In A Thriving Segment

Introduction HealthEquity (HQY) noticeably under-performed the S&P 500 in the past year, with much of the pandemic-related losses not yet recovered. This article discusses the company’s performance in 2020 along with research data on the HSA market to explain the long runway ahead for the HSA sector. Source: Seeking Alpha...

Hidden Opportunities on Seeking Alpha | September 21, 2020

HealthEquity, Inc. (HQY) CEO Jon Kessler on Q2 2021 Results - Earnings Call Transcript

HealthEquity, Inc. (HQY) Q2 2021 Earnings Conference Call Sept 08, 2020, 04:30 PM ET Company Participants Richard Putnam - IR Jon Kessler - President & CEO Steve Neeleman - Vice Chair & Founder Darcy Mott - EVP & CFO Ted Bloomberg - COO Tyson Murdock - Deputy CFO Conference Call...

SA Transcripts on Seeking Alpha | September 9, 2020

HealthEquity Announces Closing of Sale of Additional Shares

DRAPER, Utah, July 15, 2020 -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”) today announced the closing of the underwritten public offering of an.

Yahoo | July 15, 2020

HealthEquity Announces Closing of Follow-on Offering

DRAPER, Utah, July 13, 2020 -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), today announced the closing of the underwritten public offering of 4,600,000.

Yahoo | July 13, 2020

HealthEquity Announces Commencement of Proposed Offering of Common Stock

DRAPER, Utah, July 08, 2020 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), today announced that that it has…

GlobeNewswire | July 8, 2020

Read More 'HQY' Stories Here

HQY Price Returns

1-mo 24.94%
3-mo 4.29%
6-mo 9.52%
1-year -0.07%
3-year 18.64%
5-year 87.63%
YTD -22.15%
2019 24.17%
2018 27.84%
2017 15.15%
2016 61.63%
2015 -1.49%

Continue Researching HQY

Want to see what other sources are saying about Healthequity Inc's financials and stock price? Try the links below:

Healthequity Inc (HQY) Stock Price | Nasdaq
Healthequity Inc (HQY) Stock Quote, History and News - Yahoo Finance
Healthequity Inc (HQY) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7869 seconds.